CIOTechie_Healthcare_Imaging_Treatment_AtrialFibrillation_HealthIT_technology_HealthcareNews_Philips_Medtronic

Philips Partners With Medtronic To Advance The Image-Guided Treatment Of Atrial Fibrillation

Healthcare News

Philips_Partners-With-Medtronic-To-Advance-The-Image-Guided-Treatment-Of-Atrial-Fibrillation Philips Partners With Medtronic To Advance The Image-Guided Treatment Of Atrial FibrillationPhilips has established a partnership with Medtronic, a medical device company to further advance the image-guided treatment of paroxysmal atrial fibrillation (PAF), a common heart rhythm disorder. Through this collaboration, Medtronic will facilitate sales of products on behalf of Philips to offer an innovative, integrated image guidance solution for cryoablation procedures. As per the reports, over 33 million people across the world affect by Atrial fibrillation (AF).

Philips will bring the novel KODEX-EPD cardiac imaging and navigation system with cryoablation specific features to the market to allow electrophysiologists to perform cryoablation procedures with reduced need for X-ray imaging. The company’s KODEX-EPD system leverages dielectric imaging to create CT-like 3D, high-definition images of a patient’s cardiac structures in real time. It’s totally a new approach to imaging the heart, dielectric imaging provides several benefits in comparison to current approaches, for both cryo and RF ablation procedures. The technology offers real-time 3D imaging, reducing the need for X-ray imaging, as well as has mapping capabilities without the need to reset a reference point if the patient moves. Accordingly, the KODEX-EPD system offers excellent visualization and simplifies navigation, improving procedure efficiency and patient care.

Ahead of this collaboration, Business Leader at Philips EPD Solutions, Marlou Janssen stated that “Partnering with Medtronic extends the reach of our KODEX-EPD cardiac imaging and navigation system. Today, this technology is simplifying navigation, and in the future, it has the potential for a wide range of applications, including addressing the key unmet need of real-time therapy assessment – one of the more significant limitations of the current standard of care.”